Professional Documents
Culture Documents
GENOMICS
Venters diploid genome as an additional reference. Youd be crazy not to, says Scherer. Its like youd be looking at the data with one eye shut. Some researchers, including those enthusiastic about the availability of Venters diploid genome, question whether it actually sheds new light on the degree of variation that exists among individuals. As Harvards Church notes, recent studies of CNVs published by Scherer and others have emphasized the same point (see p. 1315). Venter wont be the only celebrity to have a published diploid genome for long: James Watson, co-discoverer of the structure of DNA, had his completed in May, and its now available on the Cold Spring Harbor Laboratorys Web site. And the advent of cheaper, faster technologies such as the one used to sequence Watsons genome means that a steadily increasing number of individuals will soon join the diploid genome club. As more individual genomes are sequenced, privacy questions will inevitably come to the fore. Watson requested that the status of a key gene that predisposes people to Alzheimers disease not be disclosed (Science, 30 March, p. 1780). Venter, in contrast, went buck-naked, genetically. The paper includes a lengthy table that lists more than two dozen gene variants he has that have been associated with increased risks for alcoholism, antisocial behavior, tobacco addiction, substance abuse, heart disease, and Alzheimers. Venter says he has no concerns about making this information public, stressing that, in the vast majority of cases, traits and diseases are not determined by a single gene. Will I really get Alzheimers and heart disease? asks Venter. His father was a smoker who died at 59 from sudden cardiac arrest, and his 84-year-old mother still plays golf and sails with him. Who wins out? asks Venter. Theres going to be a different answer in every one of us. In the end, says Venter, the more people who make public their complete DNA and health histories and traits, the more readily scientists will be able to interpret the stillbaffling human genome. I dont think we have anything to fear, says Venter. And JON COHEN we have a lot to gain.
7 SEPTEMBER 2007
1311